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Abstract
Backgound: The balance between human innate immune system and Candida albicans virulence signaling mechanisms
ultimately dictates the outcome of fungal invasiveness and its pathology. To better understand the pathophysiology and to
identify fungal virulence-associated factors in the context of persistence in humans, complex models are indispensable.
Although fungal virulence factors have been extensively studied in vitro and in vivo using different immune cell subsets and
cell lines, it is unclear how C. albicans survives inside complex tissue granulomas.
Methodology/Principal Finding: We developed an original model of in vitro human granuloma, reproducing the natural
granulomatous response to C. albicans. Persistent granulomas were obtained when the ratio of phagocytes to fungi was
high. This in vitro fungal granuloma mimics natural granulomas, with infected macrophages surrounded by helper and
cytotoxic T lymphocytes. A small proportion of granulomas exhibited C. albicans hyphae. Histological and time-lapse
analysis showed that C. albicans blastoconidia were located within the granulomas before hyphae formation. Using staining
techniques, fungal load calculations, as well as confocal and scanning electron microscopy, we describe the kinetics of
fungal granuloma formation. We provide the first direct evidence that C. albicans are not eliminated by immunocompetent
cells inside in vitro human granulomas. In fact, after an initial candicidal period, the remaining yeast proliferate and persist
under very complex immune responses.
Conclusions/Significance: Using an original in vitro model of human fungal granuloma, we herein present the evidence
that C. albicans persist and grow into immunocompetent granulomatous structures. These results will guide us towards a
better understanding of fungal invasiveness and, henceforth, will also help in the development of better strategies for its
control in human physiological conditions.
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Introduction
Candida spp. are polymorphic ascomycete fungi that grow either
in a unicellular blastoconidia yeast form or as hyphae [1,2]. They
live as commensal organisms with normal mucosal or cutaneous
microflora [3,4]. In approximately half of the human population,
C. albicans colonizes the gastrointestinal tract without any clinical
symptoms [5]. However, prolonged chemotherapy, immunosup-
pressive treatment, or surgical intervention in intensive care units
can turn this usually commensal yeast into a pathogen implicated
in life-threatening acute invasive candidiasis [6–11].
In the context of chronic pathologies, the two main features of
Candida infection are chronic disseminated candidiasis (CDC) also
known as hepatosplenic candidiasis and chronic mucocutaneous
candidiasis disease (CMCD). CMCD is characterized by persistent
superficial infections of the skin, nails, oral and genital mucous
membranes as well as impaired cell-mediated immunity against C.
albicans [12–14]. CDC is present almost exclusively in patients with
hematological malignancies such as acute and chronic lympho-
cytic leukemia. The risk of fungal complications increases with the
duration of the leukemia, reflecting the natural history of the
disease and the neutropenia linked to its treatment [15,16]. The
histological examinations of CMCD and CDC show evidence of
granuloma structures composed of epithelioid histiocytes, multi-
nucleated giant cells and lymphocytes with a chronic intensive
inflammatory reaction around the yeast blastoconidia or hyphae
[17]. Other studies have shown that granulomatous structures due
to fungal infections remain rare, but are very aggressive and
resistant to therapy [18–21]. The implication of inherent or
acquired T-cell immunodeficiencies in these C. albicans infections
has been recently demonstrated [14,22,23]. A better understand-
ing of the molecular basis of fungal invasiveness within granulomas
is essential for the development of better strategies for its control.
However, because of the lack of clinically relevant models, the
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3cellular organization and host-fungi interactions within the
complex granulomas have not been well -described to date. To
our knowledge there are no relevant models illustrating in vitro
granulomas, leading to clinical extrapolation.
The invasiveness of C. albicans is very closely linked to the
balance between the human innate immune system and the fungal
virulence. This ultimately dictates the outcome of pathogenic
dissemination [24,25]. During the development of candidiasis,
numerous types of immune cells including neutrophils, tissue
macrophages, monocytes and dendritic cells interact with the
fungus [26–28]. Most in vitro studies used a single cell type to
infection with C. albicans [29,30]. Other studies have described the
infection of different cell subsets of human blood [31–34].
However, these cellular models do not reflect the multi-cellular
organized structure of the granuloma. A first attempt to achieve
this used of human Peripheral Blood Mononuclear Cells (PBMC)
infected with heat-killed C. albicans [35]. Reconstituted epithelial
tissues derived from human carcinomas are also used as ‘‘host-
like’’ environments to study C. albicans virulence factors during
adherence and invasion, or to follow protective immune cytokine
production [36]. These models are often confronted with high
concentrations of heat-killed C. albicans for infection. Consequent-
ly, limitations of current experimental methodologies do not
permit the study of host-fungi interactions under pathophysiolog-
ical conditions and over long periods.
It is highly desirable to develop relevant and complementary
model systems in order to study the interactions between humans
and fungi during local tissue inflammation and chronic dissem-
inated infections. Likewise, the kinetics and nature of the cells that
interact to form a structured microenvironment during C. albicans
persistence are not fully understood.We hypothesize that C. albicans
-structured granulomas represent a source of persistence and a
way of propagating disease when mucosal barriers and blood
immune systems become weakened. To develop a granulomatous
model, we used freshly collected human PBMCs from healthy
individuals. This allowed us to evaluate the relevance of an in vitro
persistence model of C. albicans in human blood cell phagocytes in
a cellular and physiological environment that mimics the in vivo
situation. In this study, we induced a physiological granulomatous
reaction in order to investigate the kinetics of cellular interactions
during the very first stages of infection as well as during the late
stages of C. albicans persistence.
Results
Development of a Cellular Aggregation Around Live C.
albicans
The first step in the development of an in vitro human model of
C. albicans granuloma was to induce recruitment of peripheral
blood mononuclear cells around live C. albicans blastoconidia. We
first determined the optimal multiplicity of infection (MOI) of C.
albicans for use in subsequent experiments. The monocyte:yeast
MOIs ratios studied were 200:1, 400:1, 800:1 and 2000:1. These
experiments showed that phagocytes displayed high candidicidal
activity during the first 3 days after C. albicans (CAAL93) infection
(Figure 1A). For all MOIs, the surviving yeasts were then
responsible for a significant and rapid increase in the fungal load
from the fourth day post-infection. However, the MOIs 200:1,
400:1 and 800:1 caused premature destruction of granulomatous
structures due to an uncontrolled increase in the fungal load as
numerous C. albicans hyphae invaded the plate wells (Figure 1B,
arrows). By contrast, highest MOI of 2000:1, C. albicans
proliferation also induced a significant number of colony-forming
units 4 days after infection (10336284 CFU/ml). Interestingly, at
this MOI a cellular aggregation resembling to granuloma
structures were observed under light microscopy. There was also
a better capacity for limiting the spread of hyphae with the highest
MOI. These host cells and yeast aggregates remained under
control until the 6th day after infection (Figure 1C). At this point,
the presence of a limited proportion of hyphae colonized structures
(Figure 1C, right image) explained in part the higher fungal load
(40006179 CFU/ml). The MOI of 2000:1 was chosen for use in
subsequent experiments.
Characterization of C. albicans Elicited Granuloma
The progression in size of these cellular aggregates was followed
using scanning electron microscopy (SEM), as shown in Figure 2.
Between days 1 and 3 after infection, monocyte-like cells appeared
to begin to assemble, then lymphocytes rapidly flattened them-
selves around the monocyte-like cells. Progressively, between days
4 and 6 after infection, multi-layers made up of macrophages and
lymphocytes became more complex and compact, exhibiting the
characteristics of a typical granuloma. Interestingly, a matrix of
extra-cellular polymeric substance was observed under SEM, in
particular when the granuloma structures were quite mature or the
blastoconidia had filamented (Figure 2, day 6 right image).
The kinetics of granuloma formation were also studied using
time-lapse fluorescence microscopy and confocal microscopy.
These microscopy techniques were also used to localize GFP-
tagged C. albicans in the structures. Figure 3A shows a represen-
tative time-lapse sequence photographed by combined confocal
and bright-field imaging over 72 hours after infection. The
sequence showed that PBMCs began to collect around GFP-
tagged C. albicans cells, with the progressive formation of a
granulomatous structure. Fluorescence levels were low at this
stage, suggesting that the yeasts were distributed within the
granulomas. Interestingly, the fusion of two still-forming granulo-
mas was generally observed in all the donors (Video S1).
To more readily observe the yeasts, we generated granulomas
by infecting PBMCs at an MOI of 2000:1. We examined their
distribution 6 days after infection using confocal microscopy after
staining with rhodamine-phalloidin and Hoechst. C. albicans cells
were mainly observed inside granulomas, where they appeared to
be associated with the core (Figure 3B and Video S2). They were
also observed in the two morphological structures, such as
blastoconidia or as hyphae. In some cases, large hyphae emerged
from the granulomas. PBMCs appeared isolated in areas largely
invaded by C. albicans hyphae (Figure 3C and Video S3).
C. albicans polymorphism and cell populations of human
PBMC recruited after infection were characterized after plating
the granuloma structures by cytospin and staining with May-
Gru ¨nwald-Giemsa (MGG). Representative histological observa-
tions are shown in Figure 4. Four-day-old granuloma structures
were mainly characterized by the presence of yeast-infected
macrophages and/or activated macrophages (Mf) with large
vesicles: few cells appeared multi-nucleated. Lymphoid cells
resided mainly at the periphery of infected macrophages or
infiltrate the outer layer of the induced granuloma. After 6 days
of culture, lymphoid cells (Ly) and activated macrophages (Mf)
displayed a multilayer organization and the classical appearance
of a tightened granuloma. At this stage, cellular infiltration was
extremely apparent and was characterized by very large zones of
migrating cells, surrounding the granuloma structures (Figure 4A).
Confocal microscopy analysis confirmed that compacted aggre-
gates of mature macrophages (Mf) interacted with yeasts and
hyphae (Figure 4B, Video S4 and S5). Mature macrophages were
characterized by their increased cytoplasmic size and by their
ruffled cell membranes that link the adjacent cells. When stained
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ma structures revealed fungal burdens with the presence of
hyphae (Figure 4C).
Capacity of C. albicans Clinical Isolates to Induce an in
vitro Granulomatous Response
To determine whether the induction of PBMC aggregation is
isolate-specific, we repeated the above experiments at a MOI of
Figure 1. Recruitment of local human PBMCs around living C. albicans. (A): Multiplicity of infection calculations (MOIs). 10
6 cells/ml PBMC
were infected with different concentrations of yeast cells and incubated at 37uC, 5% CO2. Cellular aggregation was followed every day under light
microscopy. Uninfected PBMCs were used as a negative control of aggregation. The amount of surviving yeasts in granuloma structures at different
time points was expressed as colony-forming units per ml (CFU/ml). The data are presented as the mean 6 SD for three independent experiments,
each in triplicate. MOIs tested were: 200:1 (white column), 400:1 (light grey column), 800:1 (grey column) and 2000:1 (black column). (B): Light-
microscopic observation of a representative granuloma six days after C. albicans infection (MOI of 400:1). Large hyphae envading from granuloma
(arrows). Bar represents 50 mm. (C): Light microscopy observation of time course evolution of the granulomatous reaction after infection with C.
albicans (MOI of 2000:1). Bars represent 50 mm.
doi:10.1371/journal.pone.0040185.g001
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These C. albicans strains have been previously characterized for
their comparable in vivo virulence [37]. Interestingly, we found that
PBMC from healthy donors were not able to completely eliminate
C. albicans infection. As shown in Figure 5, after initial candidicidal
activity, both CAAL93 and DSY735 C. albicans strains induced
similarly high numbers of colony-forming units even on day 4 after
infection. However, the number of colony-forming units was
higher on day 6 after infection. Light-microscopy observation at
this time point showed the presence of some aggregates with fungal
hyphae corroborating the high CFU levels (data not shown).
In vitro Fungal Granulomatous Response is a
Phenomenon Conserved in Healthy Donors
Human PBMCs in the above experiments were specifically
capable of responding to two C. albicans strains. It is possible,
however, that where complex mixtures of immunocytes interact,
the variability between individuals may influence the progression
of the granulomatous response. Thus, we incubated human whole
PBMCs from 23 healthy donors with C. albicans (CAAL93) and
followed the granuloma formation over 6 and 7 days. As shown in
Figure 6A, the kinetics of the fungal load after infection were
comparable among the donors (p=0.220 between days 5 and 6).
After initial candidicidal activity of phagocytes at the earlier stages
of cell aggregation (between day 1 and 3), an increase in CFU
number between days 4 and 6 reflected C. albicans multiplication
and its persistence in granuloma structures. Multi-layer cellular
accumulations with differentiated cellular structures were formed
in every healthy donor tested. This granulomatous response was
also comparable across donors, both in terms of cell attraction
around C. albicans yeasts and qualitative cellular recruitment
(Figure 6B).
Light-microscopy observation of all the donors at different
incubation time points confirmed that the polarized growth of C.
albicans occasionally rupture some of the granuloma structures by
producing hyphae. However, six days after infection, this escape
phenomenon affected a small proportion of granuloma structures
(1.760.3/well) compared to intact granuloma structures (862/
well) (Figure 6C).
Characterization of Lymphocyte Subsets into
Granulomatous Structures
We then used flow cytometry to analyze the lymphocyte subsets,
which migrated around the C. albicans infected macrophages. The
granuloma structures from 13 healthy donors were isolated from
co-culture plates six days after infection with C. albicans (CAAL93).
A representative lymphocyte flow cytometry analysis from the
donors is shown in Figure 7A. The total number of lymphocytes, T
cells (CD3+), helper T cells (CD3+CD4+), cytotoxic T cells
(CD3+CD8+) and NK cells (Nkp46+CD3-) were analyzed. The
means and standard deviations of each lymphocyte subset on day
0 before C. albicans infection and 6 days after are presented in
Figure 2. Fungal granuloma progression by scanning electron microscopy. Kinetics of granuloma formation after infection with C. albicans
(MOI of 2000:1). The granuloma structures were collected at different time points from co-culture plates, and fixed in 2.5% glutaraldehyde, O.1 M
sucrose in cacodylate buffer for 1 h. After dehydratation through a gradient ethanol series and alcohol-freon substitution, specimens were coated
with 100 A ˚ of gold-palladium mix in an ion sputter and photographed under a scanning electron microscope. Bars represent 5 mm (Days 1 post-
infection), 10 mm (days 2 and 4) and 50 mm (day 6). Activated macrophages (Mf), lymphocytes (Ly).
doi:10.1371/journal.pone.0040185.g002
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no significant difference in all populations on day 0 before the
infection with C. albicans. Analysis of lymphocytes six days after
infection showed that a total of 33.2%64.4 of the cells
surrounding granulomas were lymphocytes. Among these,
74.5%61.8 were T lymphocytes. Among these, 74.7%62.7 were
T helper cells and 20.3%62.1 were cytotoxic T cells. Interestingly,
we observed a significant increase of the percentage of the
granuloma infiltrated CD4+ T lymphocytes compared to the
uninfected control on day 0 (74.7%62.7 vs. 61.1%62.8,
p=0.0038). Consequently, there was a significant reduction of
the percentage of infiltrated CD8+ T lymphocytes (20.3%62.1 vs.
Figure 3. Distribution of C. albicans cells in the granuloma. (A): For co-culture analysis by video-imaging, PBMCs were infected with C. albicans
cells containing the pACT1-GFP fusion protein at a MOI of 200:1. The cells were illuminated at day 0 and every 10 min over 72 h of incubation with a
300 W xenon lamp fitted with 488 nm excitation filter. Emission at 515 nm was used for analysis of C. albicans fluorescence with a Leica DMI6000B
camera cool Snap HQ2 and processed with Metamorph imaging software version 7.7.4.0. (B and C): For confocal microscopy imaging granulomas
were generated by infecting PBMCs at an MOI of 2000:1. Cells were stained with rhodamine-phalloidin and Hoechst six days after infection. Confocal
images showed GFP- tagged C. abicans inside granulomas (B). Large green-fluorescent hyphae of C. abicans emerging from granulomas (C). Image
scan was 1024 pixels 61024 pixels. Image size was 1212 mm.
doi:10.1371/journal.pone.0040185.g003
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the C. albicans- generated granuloma without significant differences
compared to control on day 0. The uninfected controls six days
after incubation did not show significant differences on T cell
populations compared to the control on day 0 (data not shown).
Impact of Polymorphonuclear Neutrophilic Granulocytes
(PMNs) on Granuloma Formation
PBMCs alone or PBMCs with PMNs from healthy individuals
were used to induce in vitro granulomas after C. albicans (CAAL93)
infection. Granuloma structures were compared at different time
Figure 4. Histological analysis of human cell subsets surrounding fungal granulomas. Granuloma structures were collected at different
time points of incubation, plated on glass slides with a cytospin and stained. (A): May-Gru ¨nwald-Giemsa (MGG, Sigma) staining of granulomas at
different time points. Bars represent 5 mm (Day 1), 15 mm (day 2 and 4) and 50 mm (day 6). (B): Confocal images showing the interaction between
mature macrophages and green-fluorescent C. abicans hyphae inside granulomas. (C): Grocott-Gomori methenamine silver nitrate staining of a
granuloma six days post-infection (bar represent 50 mm). Mature macrophages (Mf), lymphocytes (Ly), C. albicans (C.a).
doi:10.1371/journal.pone.0040185.g004
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PMNs were present among the PBMCs on day 0, a significant
reduction in the number of granulomas (Figure 8A) and fungal
loads (Figure 8B) was observed six days after infection compared to
PBMCs without PMN conditions. Despite this reduction, yeasts
persist however within granulomas and in some cases they
differentiated into hyphae. Confocal microscopy analyses showed
the same cellular organization of granulomas obtained after
infection of PBMC (Video S6).
Discussion
Understanding the molecular mechanisms underlying the
interaction between fungi and host cells is essential in order to
explain the saprophytic/pathologic balance of fungi species.
Considering the above, it is highly desirable to develop relevant
and complementary model systems to study host-fungi interac-
tions.
The key finding of our study is that after candidicidal activity of
human phagocytes, C. albicans is able to persist during the first days
after infection of human peripheral blood cells in vitro. Yeasts then
proliferate into granulomas providing the evidence of its ability to
persist in healthy individuals, even in the presence of immuno-
competent cells. Our observations are consistent with a significant
role of PMNs as key host effectors on C. albicans granuloma
formation early after infection, reducing the amount of in vitro
granulomas and the invasion by C. albicans hyphae. In addition,
the average lifetime of mature circulating PMNs being around 12
hours could suggest that C. albicans are rapidly phagocytosed and
killed. However, as reported previously, the small amount of
activating lymphokines that are produced under in vitro inflam-
matory conditions could lead to the prolonged lifespan of PMNs
[38–40]. Further work is needed to define the effect of phagocytes
on granuloma progression and/or resolution. These findings could
lead us to better comprehend what happens during chronic
candidiasis,
To the best of our knowledge, this is the first direct evidence that
a fungal pathogen induces granuloma structures in vitro. Through a
combination of histological staining, scanning microscopy, time-
lapse microscopy and flow cytometry, we have provided diverse
evidence supporting these findings. We found, however, that
granulomas successfully form only when very low concentrations
of blastoconidia are used to infect human phagocytes. The
granuloma-response resembled chronic human pathology, where
pathogens persist in tissue at low levels. This contrasts with
previous models using cell lines or human peripheral blood cells
[31–34,41,42], which utilized high concentrations of living or dead
C. albicans.
Under our methodological conditions, a very small proportion
of C. albicans eventually escape by forming hyphae. Our study
suggests that the rapid adaptation of a small proportion of C.
albicans population through yeast- hyphae switching could be an
evolutionary strategy to facilitate movement from granulomas to
blood vessels. However, previous observations showed that the
non-filamentous C. glabrata is also able to survive and persist in
immunocompetent mouse organs [43–45]. The secondary dis-
semination of this Candida species could depend less on its
phenotypic switching capability.
C. albicans virulence mechanisms and host cell interactions have
been well-documented with the use of different cell lines and
animal models [29,30,36,46,47]. However, the demonstration that
C. albicans can survive and persist in human immunocompetent
tissue structures is poorly documented in that literature. Some
studies described the degradation of C. albicans in murine hepatic
macrophages [41]. Other in vitro studies used the infection of
fractionated blood phagocytes by C. albicans in order to test yeast
transcriptional variations as a function of the tested phagocytes
[31–34,41,42]. Some studies have used an in vitro granuloma
model with human PBMCs [48,49] to investigate granulomatous
hypersensibility caused by antigens from the dimorphic fungus
Paracoccidioides brasiliensis. Heinemann at al. [35] proposed an in
vitro model using heat-killed C. albicans; dead yeast were chosen
because the cell wall glucans resist degradation. They described
the role of peripheral blood monocyte proliferation after infection
and the formation of irregular cellular aggregates; however, there
were no granulomas when lymphocytes were added to the
cultures. In addition, no investigation of the interaction between
live C. albicans and the host cells under granuloma contitions was
ever reported. In contrast to these previous studies, we developed a
model in which the number of phagocyted C. albicans by
monocytes was controlled, delaying the invasion and the rapid
spread of filamented yeasts from phagocytes, thus enabling their
interaction and subsequent granuloma formation. Our results also
confirm earlier observations in CDC patients that Candida spp.
burden can be very low, but yeasts can then be successfully re-
isolated many days after infection [43]. This persistence could
simulate the physiological phenomenon of dynamic latency in
patients with CDC.
Granuloma formation is an organized, cell-mediated immune
response mainly dependent on monocytes and T cells. It is well-
recognized as a central feature of the pathogenesis in humans.
Well-known infectious granulomatous diseases include tuberculo-
sis, leprosy, schistosomiasis, sarcoidosis, and leishmaniasis [50–55].
Granulomas were characterized by the presence of yeast-infected
macrophages and mature macrophages. Lastly, the migration of
many cytotoxic and helper T cells was observed. Interestingly, NK
cells were also recruited to contribute to the formation of
granulomas. These morphological and cellular characteristics are
similar to those of in vivo granulomas [53]. This in vitro human
fungal granuloma model enables the analysis of the human
granulomatous response against other fungal pathogens [48,49].
By taking into account the representative immune cells, cell
maturation studies can be suitably adapted and cell trafficking can
be followed. These studies may be carried out to see if particular
cells can migrate to the granuloma and subsequently leave these
structures. Further work is needed to define the balance between
Figure 5. Capability to C. albicans clinical isolates to generate
granulomas. Granuloma formation by different C. albicans clinical
isolates. Human PBMCs were infected with CAAL93 (black columns) and
DSY735 (grey columns) clinical isolates. Granuloma formation was
followed by light microscopy. The fungal load was expressed as CFU/ml
at different incubation times. The data are presented as the mean 6 SD
for three independent experiments, each in triplicate.
doi:10.1371/journal.pone.0040185.g005
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protection from invasive fungal infection.
These data have important implications both for the clinical
relevance of fungal granulomas and for the understanding of other
pathophysiological processes involved in fungal persistence in
humans. The clinical relevance of these observations is consistent
with other recent European studies and clinical case reports, which
have documented the presence of fungi in granulomatous
structures [18–21]. It is clear from these studies that the clinical
prognosis is often compromised when patients develop fungal
granulomas, such as Candida spp., Cryptococcus spp., and Aspergillus
spp., leading us to suggest that granulomas could be a source of
fungal persistence and antifungal resistance [18–20,56–59].
The pathogenesis of chronic disseminated candidiasis is not well
understood in humans. It seems that the invasion of Candida
species from the gastrointestinal tract into the bloodstream, as a
consequence of prolonged neutropenia and a breach in mucosal
integrity, induces prominent Candida granulomas in the liver. Our
results suggest that under these conditions C. albicans could survive
at low levels–representing a source of persistence and chronicity–
and then proliferate, leading to invasive disease propagation. That
brings us to the question of how in vivo fungal granulomas function
in order to limit infection, or how they can become a mechanism
of resistance to anti-fungal therapy. Our results describe the
creation of an organized human cellular response around yeasts,
consistent with the granulomatous structures observed in patients.
To our knowledge, the histological description of lesions from
patients with localized or disseminated fungal infections is a
narrow field of study in the medical community. Indeed, there is
limited information about in vivo fungal granuloma in the
literature.
Figure 6. Fungal granuloma-response variability between donors. (A): The fungal granuloma-response variability between healthy
individuals was analyzed by infecting the PBMCs from 23 donors with C. albicans (MOI of 2000:1). The granuloma-response was followed by
calculating the colony-forming units (CFU/ml) at different time points and by light microscopy observations. The data are presented as the mean 6
SD for 23 independent experiments. (B): Light-microscopic observation of representative granulomas from donors after six days of infection with C.
albicans. Bar represents 50 mm. (C): Number of specific granulomas per culture-well at different times of infection with C. albicans. Intact granulomas
(black columns), granulomas with C. albicans hyphae (white columns).
doi:10.1371/journal.pone.0040185.g006
C. albicans Persists within In Vitro Granulomas
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40185From the data presented above, it is evident that our concept of
C. albicans virulence mechanisms and host immune responses is
closely related to granulomatous cellular organization. The use of
different microscopy techniques has allowed for the first descrip-
tive image of the host cell components and C. albicans localization
in granulomas. Finally, it should be stressed that this first evidence
that C. albicans can be organized into physiological tissue-
structured communities in vitro could lead to a better understand-
ing of the molecular basis of the persistence, invasiveness and
aggressiveness of the fungus and, consequently, to the develop-
ment of better strategies for its control.
Materials and Methods
Cells and Plasmids
The C. albicans CAAL93 clinical isolate came from the
Mycobank of the Parasitology and Medical Mycology Depart-
ment, Nantes, France. The C. albicans DSY735 clinical isolate was
kindly provided by Pr. Dominique Sanglard from the Institute of
Microbiology, UNIL, University of Laussane [60]. Virulence of C.
albicans strains have been previously characterized. CAAL93 and
DSY735 were highly virulent in an in vivo mouse model of
disseminated candidiasis. pGFP and pACT1 plasmids were kindly
provided by Pr. Alistair Brown from the School of Medical
Sciences, University of Aberdeen, Institute of Medical Sciences,
Aberdeen. Escherichia coli KL1-blue (Stratagen) competent cells
were used for the transformation and propagation of recombinant
pGFP and pACT1 plasmids. The C. albicans CAI4 (ura-) strain and
the CIp-TDH3p-GFP in CAI4 (ura+) strain, were kindly provided
by Pr. Christophe D’Enfert, from the Fungal Biology and
Pathogenicity Unit of the Institut Pasteur, Paris, France.
Preparation of Candida albicans Blastoconidia
Suspensions
CAAL93 strain was streaked onto YPD agar (1% yeast extract,
2% peptone, 2% dextrose, 2% agar) and incubated overnight at
Figure 7. Recruitment of cell subsets in fungal granuloma. The granuloma structures were collected at different times points from co-culture
plates under light microscopy, and stained with a cocktail of fluorescent-conjugated antibodies specific to CD3, CD4, CD8, and NKp46. (A): The cells
were analyzed by flow cytometry after gating on CD3 lymphocytes: the CD3+ population was separated into conventional CD4+ and CD8+ T cells.
Natural killer cells were gated from the CD3- population. (B): Total lymphocytes, CD3+ and CD3- subsets percentages into granulomas for each donor
on day 0 (D0) and day 6 (D6) (n=13). (C): CD4+, CD8+ and NK lymphocyte cells into granulomas (n=13 donors). All data were acquired using a FACS
Canto II instrument (BD Biosciences) and analyzed with FlowJo software version 9.4.10 (Tree Star Inc) and DIVA software version 6.2 (BD).
doi:10.1371/journal.pone.0040185.g007
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and the cells were incubated overnight at 30uC in a shaking
incubator. After washing twice in phosphate-buffered saline, the
cells were suspended in RPMI 1640 (Sigma) with 8% heat-
inactivated pooled human serum at a concentration of 10
6 cells/
ml. For co-culture experiments, C. albicans cells were counted in
order to set up different Multiplicities Of Infection (MOI).
Human Peripheral Blood Mononuclear Cells and Candida
albicans Co-culture
Peripheral blood samples were obtained from healthy volun-
teers at the Etablissement Franc ¸ais du Sang, Pays de la Loire
(Nantes, France). Peripheral blood mononuclear cells (PBMC)
were isolated by gradient density sedimentation, using LMS 1077
(PAA Laboratories, Austria) lymphocyte separation medium as
described by [61]. In some experiments polymorphonuclear
neutrophilic granulocytes (PMNs) from donors were also isolated
by gradient density sedimentation and added to PBMC, in order
to test the effect of PMN on granuloma formation. All the analyses
presented were performed according to the principle expressed in
the Helsinki Declaration. Co-culture protocols were based on
previously described Mycobacterium tuberculosis granuloma experi-
ments by Altare et al., [62]. In brief, PBMCs were adjusted to a
final concentration of 10
6 cells/ml per each well. Then, yeast cells
were added to the blood cells at different MOIs and incubated at
37uC, 5% CO2. Cellular aggregation was followed daily using
light microscopy. Uninfected PBMCs were used as a negative
control. At various time points of incubation, granuloma structures
were processed for microscopic observation, as well as for
determining the amount of surviving yeast in the granuloma
structures and for flow cytometric analysis.
Colony-forming Unit Assay
Candidicidal activity of human PBMC was measured by
counting the living yeasts with a colony-counting technique
(colony-forming unit, CFU). After co-culture at different time
points, the cells were washed three times with phosphate-buffered
saline. Phagocytes in the wells were lysed with Trypsine-EDTA to
release the internalized yeasts. Serial dilutions were determined
according to the original yeast number in the culture. Suspensions
were spread on YPD plates and C. albicans colonies were counted
after 24 h of incubation at 30uC. The CFU/ml data obtained
corresponded to the fungal load of both yeasts within the
granulomas and after hyphae formation.
Scanning Electron Microscopy (SEM)
The granuloma structures from co-culture plates were collected
at different time points and fixed in 2.5% glutaraldehyde, 0.1 M
sucrose in cacodylate buffer for 1 h. The cells were washed twice
in the same buffer and then fixed with 1% Osmium in cacodylate
buffer for 1 h. After dehydration through a gradient ethanol series
and alcohol-freon substitution, the specimens were coated with
100 A ˚ of gold-palladium mix in an ion sputter (JEOL JFC 1100).
The specimens were observed and photographed under a scanning
electron microscope (JEOL 6400F).
Video Imaging
For co-culture analyzes by video imaging, PBMCs were infected
with CAI4 C. albicans cells containing the pACT1-GFP fusion
protein. Ten mg of pACT1-GFP and pGFP fluorescence negative
control plasmids were linearised by digestion with BglII and used
to transform C. albicans by electroporation. Single copy integrants
at the RPS10 locus were selected as previously described by
Barelle et al., [63]. Single colony transformants from Minimal
medium (SD) containing 2% glucose were inoculated into 1 ml of
synthetic complete-medium containing CAS amino-acids in order
to induce ACT1-GFP protein expression. The cells were
incubated for 2 h at 30uC to reach maximum fluorescence. The
cells were collected by centrifugation at 3000 g for 10 min,
analyzed to find the expression level under fluorescence micros-
copy (Leica Microsystems, Nanterre, France), and then used to
infect human PBMCs at a MOI of 200:1 as described above. This
MOI was chosen in order to increase the probability of finding
and recording the formation of granulomas. The cells were
illuminated at day 0 and every 10 min over 72 h of incubation
with a 300 W xenon lamp equipped with a 488 nm excitation
filter. Emission at 515 nm was used for analysis of C. albicans
fluorescence with a Leica DMI6000B camera cool Snap HQ2
Figure 8. Effect of PMNs on granuloma formation. PBMCs alone
or PBMCs with PMNs from healthy individuals were used to induce in
vitro granulomas after C. albicans (CAAL93) infection. Host cells were
infected with yeasts at an MOI of 2000:1 and incubated at 37uC, 5%
CO2. Cellular aggregation was followed every day under light
microscopy. Uninfected PBMCs and PMNs were used as a negative
control of aggregation. (A): The number of granulomas per well was
followed at different time points. Intact granulomas (black columns),
granulomas with C. albicans hyphae (white columns). (B): The amount of
surviving yeasts in granuloma structures at different time points was
expressed as colony-forming units per ml (CFU/ml). PBMCs with PMNs
co-cultures (black columns), PBMCs co-cultures (white columns). The
data are presented as the mean 6 SD, each experiment in triplicate
(n=5).
doi:10.1371/journal.pone.0040185.g008
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software version 7.7.4.0 (Universal Imaging, Downington, PA).
Confocal Microscopy Imaging
GFP-tagged C. albicans induced granulomas in Lab-Teck
TM
slides were washed twice in phosphate buffered saline (PBS) and
fixed with 4% paraformaldehyde for 30 min. After cell permea-
bilization with 100% acetone, nonspecific binding sites were
blocked with 1% BSA in PBS for 30 min. Rhodamine-conjugated
phalloidin (Wako; Osaka, Japan) was added at a 1:600 dilution to
stain actin filaments for 30 min at room temperature. Nuclear
DNA was stained with Hoechst in PBS for 1 min. Slides were air-
dried and mounted with Vectashield media. Fluorescence-stained
sections were examined under a Nikon A1 RSI microscope with
206 magnification at constant Z-steps of 1 mm. Laser confocal
system comprises a 65 mW Multi-Ar laser (405, 488 and 551-nm
excitations are possible). 3D Images were processed with NIS
elements version 3.21 (Nikon Instruments Inc.) and Volocity 3D
Image Analysis Software version 6.01 (PerkinElmer).
Histological Analyses
Granuloma structures were washed twice in phosphate buffered
saline containing 2% FBS, collected at different time points of
incubation and plated on glass slides with a cytospin (Cytobuckets
S, Jouan). Cells were submitted to May-Gru ¨nwald-Giemsa (MGG,
Sigma) and Grocott-Gomori methenamine silver nitrate. The
stained slides were observed using light microscopy (Zeiss Scope
A1) and phagocytosis and fungal-phagocyte interactions around
the granuloma structures were identified.
Flow Cytometry
The granuloma structures from co-culture plates were washed
twice in phosphate buffered saline containing 2% FBS and
collected at different time points under light microscopy. The cells
were suspended in the same buffer to a final volume of 200 ml and
stained with a cocktail of fluorescent-conjugated antibodies. The
antibodies were specific to CD3-Pecy7 (clone UCHT1, Beckman),
CD4-FITC (clone RPA-T4, BD Biosciences), CD8-PE (clone
RPA-T8, BD Biosciences), and NKp46 (clone BAB281, Beckman).
The cells were incubated for 30 min at 4uC in the dark, washed
twice with 2% FBS in phosphate-buffered saline and analyzed by
flow cytometry. After gating on CD3 lymphocytes, the CD3+
population was separated into CD4+ and CD8+ T cells. Natural
killer cells were gated out from the CD3- population. All data were
acquired using a FACS Canto II instrument (BD Biosciences) and
analyzed with FlowJo software version 9.4.10 (Tree Star Inc) and
DIVA software version 6.2 (BD).
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Supporting Information
Video S1 Representative movie from microscopy time
series showing PBMCs from a healthy donor infected
with GFP-tagged C. albicans cells (MOI of 200:1). The
cells were illuminated at day 0 and every 10 min over 72 h of
incubation with a 300 W xenon lamp fitted with a 488 nm
excitation filter. Emission at 515 nm was used for analysis of C.
albicans fluorescence with a Leica DMI6000B camera cool Snap
HQ2 and processed with Metamorph imaging software version
7.7.4.0.
(AVI)
Video S2 Movie from confocal microscopy series show-
ing a granuloma six days after infection with GFP-tagged
C. albicans (MOI of 2000:1). Actin filaments were stained with
rhodamine-conjugated phalloidin and nuclear DNA was stained
with Hoechst. Fluorescence-stained sections were examined under
a Nikon A1 RSI microscope with 206magnification at constant
Z-steps of 1 mm. Laser confocal system comprises a 65 mW Multi-
Ar laser (405, 488 and 551-nm excitations are possible). 3D Images
were processed with NIS elements version 3.21 (Nikon Instru-
ments Inc.) and Volocity 3D Image Analysis Software version 6.01
(PerkinElmer). Image size: 1212 mm.
(AVI)
Video S3 Movie from confocal microscopy series show-
ing large green-fluorescent hyphae of C. albicans
granulomas. Image size: 1212 mm.
(AVI)
Video S4 Representative movie from confocal micros-
copy showing mature macrophages (Mf) interacting
with C. albicans hyphae. Mature macrophages were charac-
terized by their increased cytoplasmic size and by their ruffled cell
membranes that link the adjacent cells and C. albicans. Image size:
100 mm.
(AVI)
Video S5 Representative movie from confocal micros-
copy showing mature macrophages (Mf) interacting
with C. albicans hyphae. Image size: 125 mm.
(AVI)
Video S6 Representative movie from confocal micros-
copy showing a granuloma six days after co-culture of
human PBMC and PMN with GFP-tagged C. albicans at
a MOI of 2000:1. Actin filaments were stained with rhodamine-
conjugated phalloidin and nuclear DNA was stained with Hoechst.
3D Images were processed with Volocity 3D Image Analysis
Software version 6.01 (PerkinElmer). Image size 2112 mm.
(AVI)
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